Back to Browse Journals » International Journal of Nanomedicine » Volume 1 » Issue 4

Nanocrystalline silver dressings in wound management: a review

Authors Joy Fong, Fiona Wood

Published Date February 2006 Volume 2006:1(4) Pages 441—449

DOI http://dx.doi.org/

Published 24 February 2006

Joy Fong1, Fiona Wood2
 
1Burns Unit, Burns Service, Royal Perth Hospital, west Australia 2Burns Service, Royal Perth Hospital/Princess Margaret Hospital, west Australia
Abstract: This paper describes the properties of nanocrystalline silver products (Acticoat™) and their applications and examines available evidence supporting their use in wound management. Acticoat utilizes nanotechnology to release nanocrystalline silver crystals. Acticoat releases 30 times less silver cations than silversulfadiazine cream or 0.5% silver nitrate solution but more of the silver released (by Acticoat). Silver-impregnated slow-release dressings release minute concentrations of silver which are quickly bound up by the chloride in the wound exudate. While extrapolations from in vitro and animal studies are cautious, evidence from these studies suggests Acticoat is: effective against most common strains of wound pathogens; can be used as a protective covering over skin grafts; has a broader antibiotic spectrum activity; and is toxic to keratinocytes and fibroblasts. Animal studies suggest a role for nanocrystalline silver in altering wound inflammatory events and facilitation of the early phase of wound healing. Quality human clinical trials into nanocrystalline silver are few. However, evidence suggests using Acticoat in wound management is cost effective, reduces wound infection, decreases the frequency of dressing changes and pain levels, decreases matrix metalloproteinase activity, wound exudate and bioburden levels, and promotes wound healing in chronic wounds. Although there is no in vivo evidence to suggest nanocrystalline silver is toxic to human keratinocytes and fibroblasts, there is in vitro evidence to suggest so; thus these dressings should be used cautiously over epithelializing and proliferating wounds. Future clinical research, preferably randomized controlled trials into nanocrystalline silver technology, may provide clinicians a better understanding of its applications in wound management.
Keywords: nanocrystalline, silver, burns, chronic, wounds, dressings

Download Article [PDF] 

Readers of this article also read:

Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods

Fernandez Cabada T, Sanchez Lopez de Pablo C, Martinez Serrano A, del Pozo Guerrero F, Serrano Olmedo JJ, Ramos Gomez M

International Journal of Nanomedicine 2012, 7:1511-1523

Published Date: 21 March 2012

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I

Neuropsychiatric Disease and Treatment 2012, 8:85-93

Published Date: 9 February 2012

Synthesis and characterization of electrospun polyvinyl alcohol nanofibrous scaffolds modified by blending with chitosan for neural tissue engineering

Naghavi Alhosseini S, Moztarzadeh F, Mozafari M, Asgari S, Dodel M, Samadikuchaksaraei A, Kargozar S, Jalali N

International Journal of Nanomedicine 2012, 7:25-34

Published Date: 4 January 2012

Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans

Pupe CG, Villardi M, Rodrigues CR, Rocha HVA, Maia LC, de Sousa VP, Cabral LM

International Journal of Nanomedicine 2011, 6:2581-2590

Published Date: 26 October 2011

Influence of synthetic superparamagnetic iron oxide on dendritic cells

Mou Y, Chen B, Zhang Y, Hou Y, Xie H, Xia G, Tang M, Huang X, Ni Y, Hu Q

International Journal of Nanomedicine 2011, 6:1779-1786

Published Date: 25 August 2011

Impact of a diabetic foot care education program on lower limb amputation rate

Abdullah M Al-Wahbi

Vascular Health and Risk Management 2010, 6:923-934

Published Date: 11 October 2010

Novel opportunities and challenges offered by nanobiomaterials in tissue engineering

Fabrizio Gelain

International Journal of Nanomedicine 2008, 3:415-424

Published Date: 10 August 2008

Aliskiren in hypertension: evidence for its potential therapeutic value

Doris Peter

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 31 March 2005